Cronos
CRON | NASDAQ
$3.27
-$0.11 (-3.25%)
At close: Nov 16, 2026, 4:00 PM ET
$3.29
+$0.02 (+0.61%)
After-hours:
Nov 16, 2026, 7:50 PM ET
Cronos Company Profile
Company profile explainedCompany Profile
Cronos Group Inc. is a company primarily focused on cannabinoids. In the United States, it develops, promotes, and supplies hemp-derived wellness and beauty products under the Lord Jones and Happy Dance brands, reaching consumers through online sales, traditional retail outlets, and partnerships within the hospitality sector. Beyond hemp, the company also engages in the cultivation, production, and commercialization of cannabis and its related extracts for both therapeutic and recreational consumption. Its cannabis offerings encompass dried flower, pre-rolled joints, edibles, concentrates, and various extracts, which are distributed via wholesale channels and directly to clients. The wellness segment operates under the PEACE NATURALS platform, while its adult-use products are marketed through the Spinach brand. Additionally, Cronos exports dried cannabis and cannabis oils to international markets such as Germany, Israel, and Australia. Founded in 2012, the company's headquarters are located in Toronto, Canada.
Key Executives
| Name | Position |
|---|---|
| Michael Ryan Gorenstein | President, Chief Executive Officer & Chairman |
| Anna Shlimak | Chief Financial Officer |
| Adam Wagner | General Manager of Cronos Israel |
| Arye Weigensberg | Senior Vice President and Head of Research & Development |
| Harrison Aaron | Senior Director of Investor Relations & Corporate Development |
| Jared Matthew Kenost | Principal Accounting Officer, Vice President & Controller |
| Jeffrey David Jacobson | Chief Growth Officer |
| Shannon Buggy | Senior Vice President & Global Head of People |
| Terry Gregory-Joseph Doucet | General Counsel & Corporate Secretary |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 20, 2026 | 4 | Filing |
| Oct 20, 2026 | 3 | Filing |
| Oct 15, 2026 | 8-K | Current Report |
| Sep 11, 2026 | 8-K | Current Report |
| Aug 07, 2026 | 4 | Filing |
| Aug 07, 2026 | 4 | Filing |
| Aug 07, 2026 | 4 | Filing |
| Aug 07, 2026 | 8-K/A | [Amend] Current Report |
| Aug 06, 2026 | 10-Q | Quarterly Report |
| Aug 06, 2026 | 8-K | Current Report |
Cronos
| Country | Canada |
| IPO Date | Feb 27, 2018 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 610 |
| CEO | Michael Ryan Gorenstein |
Contact Details
4491 Concession Road 12 Stayner,
ON L0M 1S0 Canada
Stock Details
| Ticker Symbol | CRON |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001656472 |
| CUSIP Number | 22717L101 |
| ISIN Number | CA22717L1013 |
| SIC Code | 2833 |
Recent News
- 8 days ago / seekingalpha.comOne Regulator Could Soon Unlock Altria And Cronos' Cannabis Fortune
- 10 days ago / seekingalpha.comCronos Group Inc. (CRON:CA) Q3 2026 Earnings Call Transcript
- 12 days ago / marketbeat.comCronos Group Q3 Earnings Call Highlights
- 12 days ago / globenewswire.comCronos Group Reports 2026 Third Quarter Results
- 18 days ago / zacks.comBaker Hughes Wins Major Subsea Contract From Eni for Cronos Gas
- 20 days ago / globenewswire.comBaker Hughes Wins Significant Subsea Production Systems and Services Award for Eni's Cronos Gas Development
- 22 days ago / zacks.comAre Medical Stocks Lagging Cronos Group (CRON) This Year?
- 25 days ago / zacks.comCronos (CRON) Upgraded to Strong Buy: Here's What You Should Know
- 1 month ago / globenewswire.comCronos Completes Acquisition of CanAdelaar, Europe's Largest Adult-Use Cannabis Company
- 1 month ago / globenewswire.comFan-Favorite and Limited-Edition Spinach® Green Apple-Flavored Products are Returning for the Fall Season
Add to Watchlist
Select watchlists to add or remove CRON